Literature DB >> 9892939

Frequency of application of topical corticosteroids: an overview.

B R Lagos1, H I Maibach.   

Abstract

The frequency of application of topical corticosteroids has remained an unresolved issue through the decades with most textbooks and physicians recommending multiple daily use. This review focuses on the rationale of once daily application of corticoids as an effective treatment in some patients. Dermatopharmacokinetic data relevant to the dosage and frequency of application of topical corticoids are discussed. Clinical trials on the efficacy of once daily vs. twice daily applications are evaluated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9892939     DOI: 10.1046/j.1365-2133.1998.02498.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis.

Authors:  James Q Del Rosso; Sanjay Bhambri
Journal:  J Clin Aesthet Dermatol       Date:  2009-09

2.  Vulvar skin atrophy induced by topical glucocorticoids.

Authors:  Elisabeth Johnson; Pamela Groben; Alisa Eanes; Priya Iyer; Joseph Ugoeke; Denniz Zolnoun
Journal:  J Midwifery Womens Health       Date:  2012 May-Jun       Impact factor: 2.388

Review 3.  Established corticosteroid creams should be applied only once daily in patients with atopic eczema.

Authors:  Hywel C Williams
Journal:  BMJ       Date:  2007-06-16

Review 4.  Treatment of Eczema: Corticosteroids and Beyond.

Authors:  Melanie Chong; Luz Fonacier
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 5.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Misuse of topical corticosteroids: A clinical study of adverse effects.

Authors:  Vivek Kumar Dey
Journal:  Indian Dermatol Online J       Date:  2014-10

7.  Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.

Authors:  Parinbhai Shah; Benjamin Goodyear; Nirali Dholaria; Vinam Puri; Bozena Michniak-Kohn
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

8.  Rational and ethical use of topical corticosteroids based on safety and efficacy.

Authors:  Sanjay K Rathi; Paschal D'Souza
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

9.  Ethical use of topical corticosteroids.

Authors:  Abir Saraswat
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

10.  Lycii radicis cortex inhibits glucocorticoid‑induced bone loss by downregulating Runx2 and BMP‑2 expression.

Authors:  Bina Lee; Sooyeon Hong; Minsun Kim; Eun-Young Kim; Hi-Joon Park; Hyuk-Sang Jung; Jae-Hyun Kim; Youngjoo Sohn
Journal:  Int J Mol Med       Date:  2021-06-24       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.